No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Administration, Cutaneous
-
Dermatologic Agents / administration & dosage
-
Dermatologic Agents / adverse effects*
-
Double-Blind Method
-
Humans
-
Ointments / administration & dosage
-
Psoriasis / drug therapy*
-
Pyrans / administration & dosage
-
Pyrans / adverse effects*
-
Receptors, Retinoic Acid / agonists*
-
Retinoic Acid Receptor gamma
-
Sulfonamides / administration & dosage
-
Sulfonamides / adverse effects*
Substances
-
Dermatologic Agents
-
GSK2981278
-
Ointments
-
Pyrans
-
Receptors, Retinoic Acid
-
Sulfonamides
Associated data
-
ClinicalTrials.gov/NCT02548052